- Filed
- Mar 26, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 29, 2024 | 49.26M sh |
| Short Term Investments | FY 2024 · Jan 31, 2023 | $127.86M |
| Current Liabilities | FY 2024 · Jan 31, 2023 | $94.96M |
| Total Liabilities | FY 2024 · Jan 31, 2023 | $102.78M |
| Current Assets | FY 2024 · Jan 31, 2023 | $229.48M |
| Total Assets | FY 2024 · Jan 31, 2023 | $253.04M |
| Shares Diluted | FY 2024 · Jan 31, 2022 | 25.78M sh |
| Capex | FY 2024 · Jan 31, 2022 | $819K |
| Operating Cash Flow | FY 2024 · Jan 31, 2022 | −$41.57M |
| Cash And Equivalents | FY 2024 · Jan 31, 2022 | $95.69M |
| Eps Diluted | FY 2024 · Jan 31, 2022 | −$2.37 |
| Eps Basic | FY 2024 · Jan 31, 2022 | −$2.37 |
| Sga Expense | FY 2024 · Jan 31, 2022 | $24.01M |
| Rd Expense | FY 2024 · Jan 31, 2022 | $51.64M |
| Net Income | FY 2024 · Jan 31, 2022 | −$58.23M |
| Operating Income | FY 2024 · Jan 31, 2022 | −$56.26M |
| Gross Profit | FY 2024 · Jan 31, 2022 | $108.76M |
| Cost Of Revenue | FY 2024 · Jan 31, 2022 | $14.78M |
| Revenue | FY 2024 · Jan 31, 2022 | $123.54M |
| Stockholders Equity | FY 2024 · Jan 31, 2021 | −$246.34M |